Novel insights into gene therapy in the cornea
- 16 November 2020
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 202, 108361
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R01EY030774, 1U01EY031650, 5R01EY017294)
- National Eye Institute
- University of Missouri
This publication has 128 references indexed in Scilit:
- The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) GenePLOS ONE, 2013
- Strategies for local gene therapy of corneal allograft rejectionMiddle East African Journal of Ophthalmology, 2013
- Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin)The Ocular Surface, 2012
- Overexpression of either lysine-specific demethylase-1 or CLOCK, but not Co-Rest, improves long-term expression from a modified neurofilament promoter, in a helper virus-free HSV-1 vector systemBrain Research, 2012
- Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the corneaNanomedicine: Nanotechnology, Biology and Medicine, 2011
- AAV serotype influences gene transfer in corneal stroma in vivoExperimental Eye Research, 2010
- Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouseExperimental Eye Research, 2010
- Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblastsBrain Research Bulletin, 2010
- Gene delivery to corneaBrain Research Bulletin, 2010
- Current status of gene delivery and gene therapy in lacrimal gland using viral vectorsAdvanced Drug Delivery Reviews, 2006